发现抗体/盐酸双哌啶/25 mg/B-115-25 mg

价格
¥1920.00
货号:B-115-25mg
浏览量:94
品牌:Discovery
服务
全国联保
正品保证
正规发票
签订合同
商品描述
Cat #: B-115
Alternative Name Akineton®, Akinophyl®
  • Lyophilized Powder
  • Bioassay Tested
  • Source Synthetic
    MW: 347.92
    Purity: >99%
    Effective concentration 0.5 nM - 100 μM.
      • Biperiden hydrochloride
    Chemical name α-Bicyclo[2.2.1]hept-5-en-2-yl-α-phenyl-1-piperidinepropanol hydrochloride.
    Molecular formula C21H29NO*HCl.
    CAS No.: 1235-82-1.
    Activity Biperiden hydrochloride is a muscarinic acetylcholine receptor (mAChR) antagonist that displays selectivity for the M1 subtype (Ki values are 0.48, 2.4, 3.9, 6.3 and 6.3 nM for M1, M4, M3, M2 and M5 receptors respectively)1. It alleviates extrapyramidal symptoms associated with antipsychotic drugs2 and displays antiparkinsonian activity3.
      • Bolden, C. et al. (1992) J. Pharmacol. Exp. Ther.  260, 576.
      • Sudo, Y. et al. (1999) Life Sci. 64, PL99.
      • Brocks, D.R. (1999) J. Pharm. Pharmaceut. Sci. 2, 39.
    Shipping and storage Shipped at room temperature. Product as supplied can be stored intact at room temperature for several weeks. For longer periods, it should be stored at -20°C. Store with a desiccant in a cool place.
    Solubility DMSO. Centrifuge all product preparations before use (10000 x g 5 min).
    Storage of solutions Up to four weeks at 4°C or three months at -20°C.
      • Biperiden hydrochloride
        Alomone Labs Biperiden hydrochloride inhibits carbachol’s effect on M1 mAChR expressed in C6 cells.
        Cells were loaded with Fluo-3 AM and changes in intracellular Ca2+ were detected via changes in Fluo-3 emission following application. A. Normalized fluorescence following application (arrow) of 10 μM Carbachol without (control) and with 10 or 100 μM Biperiden hydrochloride (#B-115), as indicated. B. Inhibition of 10 μM Carbachol effect, plotted against Biperiden hydrochloride concentrations.
    References - Scientific background
    • 1. Bonner, T.I. (1989) Trends. Neurosci. 12, 148.
    • 2. Felder, C.C. (1995) FASEB. J. 9, 619.
    • 3. Bolden, C. et al. (1992) J. Pharmacol. Exp. Ther. 260, 576.
    • 4. Eltze, M. and Figala, V. (1988) Eur. J. Pharmacol. 158, 11.
    • 5. Brocks, D.R. (1999) J. Pharm. Pharmaceut. Sci. 2, 39.
    • 6. Sudo, Y. et al. (1999) Life Sci. 64, PL99.
      • Muscarinic acetylcholine receptors (mAChR) regulate a number of important basic physiologic functions including heart rate, motor and sensory control and more complex behaviors including arousal, memory, and learning. Loss of muscarinic receptor number or function has been implicated in the etiology of several neurological disorders including Alzheimer"s dementia, Down"s syndrome, and Parkinson"s disease. Five subtypes of muscarinic receptors (m1-m5) have been identified by molecular cloning1 and much has been learned about their distribution, pharmacology, and structure2.

        Biperiden hydrochloride is a non-selective muscarinic receptor antagonist that displays selectivity for the M1 subtype (Ki values are 0.48, 2.4, 3.9, 6.3 and 6.3 nM for M1, M4, M3, M2 and M5 receptors respectively)3-4. It is antiparkinsonian5 and therefore used for the adjunctive treatment of all forms of Parkinson"s disease (postencephalitic, idiopathic, and arteriosclerotic), also commonly used to improve parkinsonian signs and symptoms related to antipsychotic drug therapy6.

    Target M1-M5 muscarinic receptors
    receive a 5 mg free trial sample!
    Last update: 25/09/2019

    Biperiden hydrochloride (#B-115) is a highly pure, synthetic, and biologically active compound.

    For research purposes only, not for human use
    Discovery®抗体是Cambridge Research Biochemicals的目录抗体业务。 CRB是全球第二大最古老的肽公司,也是抗体研究市场的先驱,目前正以Discovery®Antibodies的名义建立一系列新验证的靶标抗体。 Discovery®抗体将专注于研究用抗体(早期药物“发现”),并将补充我们非常成功且长期存在的定制抗体业务(www.crbdiscovery.com)。我们已经以新颖,复杂,稀有和翻译后修饰的特异性抗体而闻名,这些受追捧的靶标将出现在我们的Discovery®Antibody目录范围内。  我们于2017年2月,在发现肽之后一年,并且在詹姆斯·库克船长(他当时最伟大的探险家)于1776年从英国出发,乘坐“ HMS发现”号开始租用新水域和“发现全球各地的新土地。因此,“发现”这个名称似乎适合东北制造商–詹姆斯·库克的故乡。 在1700年代后期对全球新发现土地的追求与医学研究的新“发现”以及2000年人类基因组图谱的发现之间,还有其他相似之处。  有关更多详细信息,请参见有关Discovery®抗体发布的新闻稿。   Cambridge Research Biochemicals  (www.crbdiscovery.com)成立于1980年,是英国领先的定制肽和抗体工具的独立生产商,为全球制药,生命科学和学术领域的研究人员提供产品。其产品的主要应用是定制的实验室规模试剂,用于早期药物发现中的主要研究证据,并支持临床研究中的生物标志物计划。该公司生产各种口味的肽,从简单到修饰,稳定和放射性标记,再到从毫克到克到最高纯度的染料标记。此外,CRB是产生高度特异性和靶向抗体(多克隆抗体和单克隆抗体)的公认专家。荧光染料标记也是重点。自1994年以来,该公司于2016年启动了其首个目录业务DISCOVERY®。
    • 资质认证

      获得国家资质,权威认证!

    • 全国联保

      全国联保,官方无忧售后

    • 正规发票

      正规发票,放心购买

    • 签订合同

      签订合同,保障您的权益

    /**/